Aldeyra Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Aldeyra Therapeutics, Inc.
CIK #0001341235
EDGAR Form CIK 2011 - 2024
10-K [0001341235]
10-Q [0001341235]
3 [0001341235]
4 [0001341235]
8-K [0001341235]
D [0001341235]
SC 13G [0001341235]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Group Inc Aldeyra Therapeutics Inc [2024-02-13]
BlackRock Inc Aldeyra Therapeutics Inc [2024-01-29]
Knoll Capital Management LLC Aldeyra Therapeutics Inc [2023-10-04]
BlackRock Inc Aldeyra Therapeutics Inc [2022-07-08]
State Street Corp Aldeyra Therapeutics Inc [2022-02-09]
BlackRock Inc Aldeyra Therapeutics Inc [2022-02-04]
ProSight Management LP Aldeyra Therapeutics Inc [2020-02-25]
BlackRock Inc Aldeyra Therapeutics Inc [2020-02-07]
Adage Capital Partners GP LLC Aldeyra Therapeutics Inc [2019-09-27]
683 Capital Management LLC Aldeyra Therapeutics Inc [2018-01-22]
View All
Form 3/4/5 Subject 2011 - 2024
Aldeyra Therapeutics, Inc.
Alfieri Michael
Machatha Stephen
Greenberg Bruce
Walker Neal
Douglas Richard
Joyce Martin Joseph
Miller-Rich Nancy
Phillips Gary M.
Bronstein Ben
Edelman Joseph
Perceptive Advisors LLC
Perceptive Life Sciences Master Fund Ltd
Brady Todd C
Reed Joshua
Treu Jesse I
McMullin David
Clark David J
Tulipano Stephen J
Clarke C. Boyd
Young Scott
Shah Nimesh
Blair James C
Domain Partners VI, L.P.
Vitullo Nicole
Schoemaker Kathleen K
Dovey Brian H
Johnson & Johnson
Johnson & Johnson Innovation - JJDC, Inc.
DP VI Associates, L.P.
Domain Associates
Kamdar Kim P.
Halak Brian K
Terms | Privacy | Guide
tony@aum13f.com